Newsroom

News

SARS-CoV-2 infections pose a global threat to human health and a formidable research challenge. One of the most urgent tasks is to gain a detailed understanding of the molecular interactions between the virus and the cells it infects. It must also be clarified, whether these interactions favour the multiplication of the virus or - on the contrary - activate defence mechanisms. In order to multiply, SARS-CoV-2 uses proteins of the host cell. However, thus far no detailed information on the part of the human proteome - i.e. the total of all proteins occurring in human cells – that is in direct contact with the viral RNA existed. This void has now been filled. Scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) Würzburg, the Julius-Maximilians-Universität Würzburg (JMU) and the Broad Institute (Cambridge, USA) have succeeded in creating the first global atlas of direct interactions between the SARS-CoV-2 RNA and the proteome of the human host. The HIRI is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, in collaboration with JMU. In addition, the authors identified important regulators of viral replication. Dr Mathias Munschauer from HIRI and Professor Jochen Bodem from the Institute of Virology and Immunobiology at JMU were responsible for the study. They present the results of their work in the latest issue of the journal Nature Microbiology.

21.12.2020

HIRI

News

Prof Rolf Müller, Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), has been awarded the Gottfried Wilhelm Leibniz Prize 2021 by the German Research Foundation (DFG) for his outstanding research achievements. The Leibniz Prize is the most highly endowed award regularly presented to scientists in Germany. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, in collaboration with Saarland University.

10.12.2020

HIPS

Arme und Hände die auf einer Tastatur liegen

News

Der Haushaltsausschuss des Bundes hat dem Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) Förderung in Höhe von 47 Millionen Euro für den weiteren Ausbau des Instituts zugesichert. Zusammen mit Mitteln aus dem Landeshaushalt des Saarlandes erhält das HIPS bis 2025 somit eine Gesamtsumme von 70 Millionen Euro. Geplant sind ein Erweiterungsbau und weitere Forschungsgruppen mit Fokus auf antibakteriellen und antiviralen Wirkstoffen.

01.12.2020

HIPS

Elektronenmikroskopische Aufnahme von Staphylokokken auf HeLa-Zellen.

News

Hospital-acquired bacterial pneumonia is the most frequent nosocomial infection. It is mostly caused by the bacterium Staphylococcus aureus, which in many cases is already resistant to commonly used antibiotics and is therefore difficult to treat. A team from the Helmholtz Centre for Infection Research (HZI) in cooperation with the Lead Discovery Center GmbH (LDC), a spin-off of Max Planck Innovation and the Max Planck Society e.V., aims to further develop a drug that prevents staphylococci from colonizing the lungs. The research team will now receive milestone-dependent funding of initially 1.33 million US dollars from the non-profit organization CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), with CARB-X anticipating a further 7.44 million US dollars depending on the progress of the project.

01.12.2020

HZI Campus

Die entwickelten Pathoblocker inaktivieren das Enzym LasB und entwaffnen somit den Krankheitserreger Pseudomonas aeruginosa.

News

01.12.2020

HZI Campus

HIPS

Prof. Alice McHardy und Prof. Jörg Vogel

News

The annual list of “Highly-cited researchers” identifies scientists who have demonstrated a significant impact in their chosen field over the last ten years through the publication of several highly-cited papers. This year, the Braunschweig Helmholtz Centre for Infection Research (HZI) has two researchers on the list: bioinformatician Prof Alice McHardy and biochemist Prof Jörg Vogel. The ranking by Clarivate Analytics, a company specialising in bibliometric data, includes more than 6,100 researchers.

30.11.2020

HZI Campus

HIRI

Back to the first page
...
57
58
59
60
...
149

HZI in the media

... “, sagte die Leiterin der Epidemiologie am Braunschweiger Helmholtz-Zentrum für Infektionsforschung.

Lange betonte, flächendeckende ...

28.11.2025

Evangelische Zeitung

... ein Zentrum für Quantentechnologie entstehen und das Helmholtz-Institut für Pharmazeutische Forschung ausgebaut werden.

Mehr ...

27.11.2025

Tagesschau

Euro werden investiert in die Erweiterung des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS). Und ...

27.11.2025

ZEIT online

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

The

26.11.2025

Medical Xpress

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025

DeutschesGesundheitsPortal

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025

Regional Heute

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025

Medizinische Hochschule Hannover

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025

Bochumer-Zeitung

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025

Bilanz

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025

Rheinische Post

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.